We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Way Found to Slow Growth of Kaposi Sarcoma

By Biotechdaily staff writers
Posted on 12 May 2006
Cancer researchers have found that inhibiting the activity of heme oxygenase-1 (HO-1) slows the growth of Kaposi sarcoma, a type of cancer characterized by numerous bluish-red nodules on the skin, usually on the lower extremities, that is endemic to equatorial Africa and often occurs in a particularly virulent form in people with AIDS. More...


Investigators at the Universidad Autonoma de Madrid (Spain) built upon previous findings that infection with Kaposi sarcoma-associated herpes virus caused increased HO-1 activity in Kaposi sarcoma cells. The increase was induced by a viral protein, viral G protein-coupled receptor (vGPCR).

In the current work, published in the April 21, 2006, issue of the Journal of Biological Chemistry, the investigators used various methods to inhibit the expression of HO-1. They found that suppression of HO-1 dramatically reduced growth of Kaposi sarcoma tumors transplanted into nude mice. Treating the mice with an HO-1 inducer stimulated tumor growth.

First author Dr. Maria Julia Marinissen, a researcher at the Universidad Autonoma de Madrid, said, "Considering that heme oxygenase-1 is overexpressed in human Kaposi sarcoma lesions, the inhibition of intratumoral heme oxygenase-1 activity by currently available drugs can represent a new anticancer tactic in the treatment of Kaposi sarcoma and may be of potential clinical interest after more extensive investigation.”


Related Links:
Universidad Autonoma de Madrid

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Aspiration System
VACUSAFE
New
Steam Sterilizer
Hi Vac II Line
New
Prefilled Tubes
Prefilled 5.0ml Tubes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.